FENC - Fennec Pharmaceuticals Inc.

Over the past 90 days, insiders at Fennec Pharmaceuticals Inc. (FENC) have been net sellers, shedding 112,545 shares worth roughly $1.3M on balance.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Southpoint Capital Advisors LP	2.74M	$29.37M	-
CFO	Robert Andrade	248.6K	$2.66M	-
Dir	Rosty Raykov	124.4K	$1.33M	-
CEO	Jeffrey S. Hackman	70.8K	$758.0K	-
Dir	Chris A Rallis	63.1K	$674.9K	-

Buys and sells only

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 15, 2024	Chris A Rallis60	Director	Sale+OE10b5-1	800	$10.45	$8,360.00	-1.8%	-36.7%	-49.2%
Apr 5, 2024	Rosty Raykov51	Chief Executive Officer	Sell10b5-1	88,583	$10.82	$958,668.92	-32.1%	-45.7%	-50.9%
Apr 3, 2024	Rosty Raykov51	Chief Executive Officer	Sell10b5-1	40,584	$10.78	$437,451.07	-12.8%	-44.0%	-48.1%
Apr 1, 2024	Rosty Raykov51	Chief Executive Officer	Buy	29,167	$0.00	-	+10.1%	-42.2%	-49.0%
Apr 1, 2024	Robert Andrade69	Chief Financial Officer	Buy	12,500	$0.00	-	+13.6%	-42.2%	-49.0%
Mar 26, 2024	Robert Andrade69	Chief Financial Officer	Sell	13,975	$10.90	$152,345.67	-13.2%	-41.7%	-40.6%
Mar 26, 2024	Chris A Rallis60	Director	Sale+OE10b5-1	2,114	$10.97	$23,190.58	-4.9%	-41.7%	-40.6%
Mar 25, 2024	Robert Andrade69	Chief Financial Officer	Sell10b5-1	13,975	$11.00	$153,690.06	-11.7%	-42.3%	-41.5%
Jan 5, 2024	Robert Andrade69	Chief Financial Officer	Sell10b5-1	30,000	$10.53	$315,750.00	-20.0%	+5.4%	-40.6%
Dec 28, 2023	Rosty Raykov51	Chief Executive Officer	Sale+OE	3,656	$11.55	$42,226.80	-1.3%	-4.5%	-46.4%